Allernest Liquid
NDC Package 60986-1003-4
Package Information
Allernest (formicum acidum, lachesis mutus, luffa operculata. petroleum, rhus toxicodebdron, aralai racemosa, galphimia glauca, thuja occidentalis, urtica dicica and cardiospermum) liquids is a medication used as Relief of mild allergic reactions. This formulation utilizes a liquid delivery system. Marketed by Marco Pharma International Llc., this product is identified by NDC 60986-1003.
Identification & Billing
Clinical Specifications
- ARALIA RACEMOSA ROOT 4 [hp_X]/mL
- CARDIOSPERMUM HALICACABUM FLOWERING TOP 3 [hp_X]/mL
- FORMIC ACID 12 [hp_X]/mL
- GALPHIMIA GLAUCA FLOWERING TOP 4 [hp_X]/mL
- KEROSENE 6 [hp_X]/mL
- LACHESIS MUTA VENOM 8 [hp_X]/mL
- LUFFA OPERCULATA FRUIT 6 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG 4 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/mL
- URTICA DIOICA 4 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 60986 - Marco Pharma International Llc.
- 60986-1003 - Allernest
- 60986-1003-4 - 100 mL in 1 BOTTLE, GLASS
- 60986-1003 - Allernest
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (60986-1003). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60986-1003-4 identifies a specific commercial package of 100 ml in 1 bottle, glass of Allernest, a human over the counter drug labeled by Marco Pharma International Llc.. This liquid is formulated for oral use and contains aralia racemosa root; cardiospermum halicacabum flowering top; formic acid; galphimia glauca flowering top; kerosene; lachesis muta venom; luffa operculata fruit; thuja occidentalis leafy twig; toxicodendron pubescens leaf; urtica dioica as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Marco Pharma International Llc. on November 18, 2011. The current certification is valid through December 31, 2027.
How is this Marco Pharma International Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60986100304. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.